You have 9 free searches left this month | for more free features.

pMMR/MSS

Showing 1 - 25 of 170

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

Recruiting
  • Locally Advanced Colorectal Carcinoma
  • Beijing, Beijing, China
    Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023

Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Beijing, China
  • +1 more
Sep 21, 2023

Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • mCRC
  • Tislelizumab & Fruquintinib
  • Guangzhou, Guangdong, China
  • +1 more
Jan 25, 2023

Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

Not yet recruiting
  • Locally Advanced Colorectal Cancer
  • (no location specified)
Oct 18, 2022

Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • CapOx(Capecitabine+ Oxaliplatin)
  • +2 more
  • (no location specified)
Oct 18, 2022

Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 5, 2023

Rectal Cancer Trial (Short-course radiotherapy combined with furoquintinib and PD-1 mAb)

Not yet recruiting
  • Rectal Cancer
  • Short-course radiotherapy combined with furoquintinib and PD-1 monoclonal antibody
  • (no location specified)
Aug 29, 2023

Colorectal Cancer Trial in Harbin (AK119, AK112, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • Harbin, China
    Cancer Hospital Affiliated to Harbin Medical University
May 5, 2023

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Rectal Cancer, MSS Trial in Beijing (Cadonilimab, Oxaliplatin, Capecitabine)

Recruiting
  • Rectal Cancer
  • MSS
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Colorectal Cancer Metastatic Trial in Guangzhou (Sintilimab, Oxaliplatin, Capecitabine)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 24, 2021

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

Lynch Syndrome Trial in Guangzhou (PD-1 antibody)

Recruiting
  • Lynch Syndrome
  • PD-1 antibody
  • Guangzhou, Guangdong, China
    651 Dongfeng Road East
Apr 10, 2021

Mismatch Repair-proficient, Colorectal Cancer Metastatic, Microsatellite Stable Trial in Hangzhou (Tislelizumab, Irinotecan,

Recruiting
  • Mismatch Repair-proficient
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Dec 17, 2021

Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

Not yet recruiting
  • Multiple Cancer
  • Colorectal Cancer
  • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
  • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
  • (no location specified)
Aug 20, 2023

Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer Trial in Milano

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • +3 more
  • Milano, MI, Italy
    Istituto Nazionale dei Tumori
Jan 24, 2022

MSS, pMMR, Metastatic Colorectal Adenocarcinoma Trial in Shenyang (TKI ± anti-PD-1 antibody)

Recruiting
  • MSS
  • +2 more
  • TKI ± anti-PD-1 antibody
  • Shenyang, Liaoning, China
    Cancer Hospital of China Medical University/Liaoning Cancer Hosp
Sep 28, 2021

Advanced Microsatellite Stable Colorectal Cancer, Metastatic Microsatellite-stable Colorectal Cancer Trial (Sintilimab,

Not yet recruiting
  • Advanced Microsatellite Stable Colorectal Cancer
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Feb 3, 2021

Locally Advanced Rectal Cancer Trial in Guangzhou (Fruquintinib plus Tislelizumab)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Fruquintinib plus Tislelizumab
  • Guangzhou, Guangdong, China
    651 Dongfeng Road East
Aug 3, 2021

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in Hangzhou (Bevacizumab, Tripleitriumab)

Unknown status
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital of Medical College of Zhejiang Un
Sep 15, 2020

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

The mCRC pMMR/MSS or dMMR/MSI-H Status Received Palliative

Completed
  • Colorectal Cancer Metastatic
  • +2 more
    • Guangzhou, Guangdong, China
      Sun yat-sen university cancer center
    Jul 23, 2020

    Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

    Recruiting
    • Toripalimab
    • Radiation
    • Hangzhou, Zhejiang, China
      Zhengjiang Cancer Hospital
    Dec 29, 2022